Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Sci Rep ; 12(1): 20341, 2022 11 25.
Article in English | MEDLINE | ID: mdl-36434090

ABSTRACT

Fused filament fabrication (FFF) represents a straightforward additive manufacturing technique applied in the medical sector for personalized patient treatment. However, frequently processed biopolymers lack sufficient thermal stability to be used as auxiliary devices such as surgical guides. The aim of this study was to evaluate the dimensional accuracy of experimental biocopolyester blends with improved thermal characteristics after printing, annealing and sterilization. A total of 160 square specimens and 40 surgical guides for oral implant placement were printed. One subgroup of each material (n = 10) underwent thermal annealing before both subgroups were subjected to steam sterilization (134 °C; 5 min). Specimens were digitized and the deviation from the original file was calculated. The thermal behavior was analyzed using differential scanning calorimetry and thermogravimetric analysis. A one-way ANOVA and t-tests were applied for statistical analyses (p < 0.05). All biocopolyester blends showed warpage during steam sterilization. However, the material modification with mineral fillers (21-32 wt%) and nucleating agents in combination with thermal annealing showed a significantly reduced warpage of printed square specimens. Geometry of the printing object seemed to affect dimensional accuracy, as printed surgical guides showed less distortion between the groups. In summary, biocopolyesters did benefit from fillers and annealing to improve their dimensional stability.


Subject(s)
Printing, Three-Dimensional , Steam , Humans , Sterilization
2.
Sci Rep ; 12(1): 19119, 2022 11 09.
Article in English | MEDLINE | ID: mdl-36351929

ABSTRACT

Exposure to beryllium (Be) can lead to lung pathologies, such as chronic beryllium disease (CBD). This occupational illness has been more prevalent among dental technicians compared to the non-exposed population. Although most manufacturers state that dental materials are Be-free, this prevalence raises the question of whether the materials are completely devoid of Be-traces. Thus, the objective of the present study was to analyze the elemental composition, with emphasis on Be, of a wide range of commercially available dental materials frequently used by dental laboratories. Samples of 32 different materials were collected and analyzed using inductively coupled plasma-optical emission spectrometry (ICP-OES) and X-ray fluorescence spectroscopy. The results showed that the Be content was below the limit of quantification in all included samples (< 0.00005 mass-%). Therefore, it can be concluded that possible traces of Be were below clinical relevance in dental materials. Exposure of dental technicians to alternative Be sources should be further evaluated.


Subject(s)
Beryllium , Occupational Exposure , Beryllium/analysis , Spectrometry, X-Ray Emission/methods , Dental Materials , Occupational Exposure/analysis
3.
J Dent Res ; 96(1): 38-46, 2017 01.
Article in English | MEDLINE | ID: mdl-27625355

ABSTRACT

To determine the survival rate and marginal bone loss (MBL) of zirconia dental implants restored with single crowns or fixed dental prostheses. An electronic search was conducted up to November 2015 (without any restriction regarding the publication time) through the databases MEDLINE (PubMed), Cochrane Library, and EMBASE to identify randomized controlled clinical trials and prospective clinical trials including >15 patients. Primary outcomes were survival rate and MBL. Furthermore, the influence of several covariates on MBL was evaluated. Qualitative assessment and statistical analyses were performed. This review was conducted according to preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines for systematic reviews. With the applied search strategy, 4,196 titles could be identified. After a screening procedure, 2 randomized controlled clinical trials and 7 prospective clinical trials remained for analyses. In these trials, a total of 326 patients received 398 implants. The follow-up ranged from 12 to 60 mo. Implant loss was mostly reported within the first year, especially within the healing period. Thereafter, nearly constant survival curves could be observed. Therefore, separate meta-analyses were performed for the first and subsequent years, resulting in an implant survival rate of 95.6% (95% confidence interval: 93.3% to 97.9%) after 12 mo and, thereafter, an expected decrease of 0.05% per year (0.25% after 5 y). Additionally, a meta-analysis was conducted for the mean MBL after 12 mo, resulting in 0.79 mm (95% confidence interval: 0.73 to 0.86 mm). Implant bulk material and design, restoration type, and the application of minor augmentation procedures during surgery, as well as the modes of temporization and loading, had no statistically significant influence on MBL. The short-term cumulative survival rates and the MBL of zirconia implants in the presented systematic review are promising. However, additional data are still needed to confirm the long-term predictability of these implants.


Subject(s)
Dental Implants , Zirconium/therapeutic use , Dental Implants/adverse effects , Dental Prosthesis, Implant-Supported/adverse effects , Dental Prosthesis, Implant-Supported/methods , Dental Restoration Failure , Humans , Treatment Outcome , Zirconium/adverse effects
4.
Metabolism ; 45(8 Suppl 1): 111-4, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8769401

ABSTRACT

The first gamma knife (GK) treatment of a pituitary adenoma in 1967 was meant as an alternative to the primitive surgical approaches that prevailed at the time, with consequent unsatisfactory results. Surprisingly, pituitary adenomas still account for only 7.8% of the 27,000 cases treated in GK centers worldwide. Transnasosphenoidal surgery has greatly improved and surgeons are reluctant to give up a relatively safe and effective operative technique. Radiosurgery is not currently vying to be the primary method of "surgery", but has a definite role following failed pituitary surgery and for tumors that extend into the cavernous sinus. Of 300 patients treated in our GK service, 30 had pituitary adenomas and most had undergone surgery. To date, we have not noted any side effects in the pituitary group. Published information is also reviewed and divided, where possible, into the pre-computed tomography (CT) era and the era of CT-magnetic resonance imaging (MRI). Growth hormone (GH)-secreting adenomas and prolactinomas tend to be larger and cannot be treated with the high doses successful against corticotropin (ACTH)-secreting tumors in Cushing's disease. Radiation fall-off is steep in GK radiosurgery, with the 20% isodose curve being only millimeters away from the point of maximal radiation. The effective dose has mostly been decided on the basis of maintaining safe levels at the sensitive perisellar neural structures. The safety of GK treatment (with no mortality and no permanent morbidity) is compared with other radiosurgical techniques. Good patient response owes much to the cumulative experience of GK pioneers and also to recent advances in images and computers that have enabled increasingly precise stereotaxic targeting and dose planning.


Subject(s)
Adenoma/surgery , Pituitary Neoplasms/surgery , Radiosurgery , Stereotaxic Techniques , Humans , Radiosurgery/adverse effects , Treatment Outcome
5.
J Pediatr Endocrinol ; 6(3-4): 345-56, 1993.
Article in English | MEDLINE | ID: mdl-7921004

ABSTRACT

Magnetic resonance images of the pituitary-hypothalamic area in patients with GH secretory disorders, divided into two groups (hypersecretory and hyposecretory), were studied. In the first group there were 42 patients with pituitary adenoma; size, signal characteristics, direction of growth, and type of enhancement were analyzed and compared with similar studies in 40 age and sex matched control patients with non-GH secreting pituitary adenomas. No significant differences were found except for a higher frequency of chiasm involvement and a more pronounced contrast enhancement in the control group. The hyposecretory group was composed of 101 patients with congenital idiopathic growth hormone deficiency (CIGHD). MR revealed morphological abnormalities consisting of hypoplastic anterior pituitary and ectopic posterior pituitary (PPE) in 59 patients, without evidence of a complete pituitary stalk; in 42 patients the posterior pituitary was in normal position and the pituitary stalk visible. The group with PPE showed a greater frequency of multiple pituitary hormone deficiency (51% vs 12%), breech delivery (30% vs 7%) and associated congenital brain anomalies (12% vs 7%). These data suggest that CIGHD could be the result of a congenital midline brain anomaly in a significant proportion of patients.


Subject(s)
Endocrine System Diseases/diagnosis , Endocrine System Diseases/metabolism , Growth Hormone/metabolism , Magnetic Resonance Imaging , Adenoma/diagnosis , Adenoma/metabolism , Adult , Aged , Choristoma/diagnosis , Endocrine System Diseases/pathology , Female , Growth Hormone/deficiency , Humans , Male , Middle Aged , Pituitary Gland/abnormalities , Pituitary Gland/pathology , Pituitary Neoplasms/diagnosis , Pituitary Neoplasms/metabolism
6.
J Comput Assist Tomogr ; 16(1): 77-83, 1992.
Article in English | MEDLINE | ID: mdl-1729312

ABSTRACT

To evaluate the usefulness of structural and biochemical imaging techniques for the diagnosis of uveal melanoma, 12 patients with choroidal melanoma were examined. Magnetic resonance imaging was used in 11 of 12 patients, as one had a metal prosthesis. All the subjects underwent single photon planar scintigraphy (SPPS) and single photon emission computed tomography (SPECT) using the 99mTc-labeled F(ab')2 of the anti-melanoma monoclonal antibody 225.28S ([99mTc]MoAb) and positron emission tomography (PET) using [18F]fluorodeoxyglucose ([18F]FDG). Magnetic resonance identified 6 of 11 melanotic lesions (definite melanomas) and 4 of 11 hypomelanotic lesions (probable melanomas), whereas in one case it was inconclusive. [99mTc]MoAb uptake was observed in 5 of 12 lesions using SPPS and 8 of 12 lesions using SPECT. [18F]FDG uptake was observed in 3 of 12 lesions by PET. These results demonstrate that both MR and radioimmunoscintigraphy are sensitive techniques for the diagnosis of choroidal melanomas and suggest that the detection of melanomas by MR, SPPS, and SPECT is largely dependent upon their size. The validity of these conclusions was verified in four subjects in whom the diagnosis was based on MR and/or SPECT findings only and confirmed by histology. The finding that only some of the uveal melanomas of larger size are visualized based on [18F]FDG uptake suggests that melanomas can have either high or low glucose consumption.


Subject(s)
Deoxyglucose/analogs & derivatives , Magnetic Resonance Imaging , Melanoma/diagnosis , Radioimmunodetection , Uveal Neoplasms/diagnosis , Choroid Neoplasms/diagnosis , Choroid Neoplasms/diagnostic imaging , Ciliary Body , Fluorodeoxyglucose F18 , Humans , Melanoma/diagnostic imaging , Tomography, Emission-Computed , Tomography, Emission-Computed, Single-Photon , Uveal Neoplasms/diagnostic imaging
8.
AJNR Am J Neuroradiol ; 4(3): 601-3, 1983.
Article in English | MEDLINE | ID: mdl-6410808

ABSTRACT

Forty patients with symptoms and signs of radicular disease or spinal cord involvement secondary to cervical spondylosis were studied with myelography (using nonionic water-soluble contrast medium) followed by computed tomographic (CT) myelography. In 17 patients CT was also performed before myelography. CT myelography adds useful information to the myelographic findings. Cord compression is better evaluated and osteophytes can be differentiated from disk herniation. Plain CT can demonstrate a herniated disk but with less accuracy than CT myelography. Cord and root compression are not seen directly on plain CT; for this reason myelography should be the first procedure in patients with myelopathy or myeloradiculopathy, which may be followed by CT myelography.


Subject(s)
Myelography , Nerve Compression Syndromes/diagnostic imaging , Spinal Cord Compression/diagnostic imaging , Spinal Nerve Roots/diagnostic imaging , Spinal Osteophytosis/diagnostic imaging , Tomography, X-Ray Computed , Adult , Aged , Cervical Vertebrae/diagnostic imaging , Female , Humans , Male , Middle Aged
9.
Ital J Neurol Sci ; 3(3): 221-7, 1982 Oct.
Article in English | MEDLINE | ID: mdl-7161037

ABSTRACT

Three patients with angiographic and CT findings of cerebral sinovenous occlusion are described. Filling defects within the venous pathways are well demonstrated by angiography. Some of the most characteristic CR signs are here described. Full evaluation, including the clinical history, angiography and computed tomography is essential.


Subject(s)
Cerebral Angiography , Sinus Thrombosis, Intracranial/diagnostic imaging , Tomography, X-Ray Computed , Adolescent , Adult , Female , Humans , Male , Sinus Thrombosis, Intracranial/physiopathology
10.
Neuroradiology ; 23(3): 123-6, 1982.
Article in English | MEDLINE | ID: mdl-7088281

ABSTRACT

Thirty patients with macroprolactinomas were treated with dopaminergic drugs from a minimum of 4 months to a maximum of 6 years. Tumor size was evaluated with serial CT during treatment; serum prolactin levels and visual fields were also assessed at the same time. Reduction of PRL levels was found in 28 patients of whom 20 also had marked reduction of tumor volume on CT. Two patterns of reduction of size of tumor in relation with time were observed. In one, tumor shrinkage occurred rapidly in the first month and even in the first week after starting treatment. In the other pattern the tumor reduced in size only after some months of treatment. It is proposed that all patients with macroprolactinomas should be treated medically before considering surgery. A radiological diagnostic and research protocol is proposed, including scout views, thin slices, coronal sections, objective measurement of tumor size and density, serial CTs at 7,21,45 days, 6 months and then every year after the beginning of treatment.


Subject(s)
Pituitary Neoplasms/diagnostic imaging , Prolactin/metabolism , Tomography, X-Ray Computed , Adolescent , Adult , Bromocriptine/therapeutic use , Female , Humans , Lisuride/therapeutic use , Male , Middle Aged , Pituitary Neoplasms/drug therapy , Pituitary Neoplasms/metabolism , Pituitary Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...